Guatemala vs Türkiye: Previously treated cases tested for RR-/MDR-TB
Guatemala
85.0%
in 2024
Türkiye
86.0%
in 2024
Guatemala rank
100th
Türkiye rank
97th
Previously treated cases tested for RR-/MDR-TB over time
- Guatemala
- Türkiye
How they compare
Türkiye currently reports 86.0% against 85.0% in Guatemala, a difference of 1.0%.
The two have swapped places 7 times across 19 shared years of data; in 2005 it was Guatemala ahead.
Guatemala ranks 100th and Türkiye ranks 97th of 180 countries.
Across the 3 decades both report, Guatemala averaged higher in 1 and Türkiye in 2.
Head to head by decade
| Decade | Guatemala | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.8% | 36.5% | 0.8% | Türkiye |
| 2010s | 49.2% | 60.7% | 11.5% | Türkiye |
| 2020s | 91.2% | 83.0% | 8.2% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guatemala or Türkiye?
- Türkiye, at 86.0% against 85.0% in Guatemala as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guatemala and Türkiye?
- 1.0%, with Türkiye ahead.
- How many years of comparable data are there for Guatemala and Türkiye?
- 19 years are reported by both, from 2005 to 2024.
- How do Guatemala and Türkiye rank globally for previously treated cases tested for rr-/mdr-tb?
- Guatemala ranks 100th and Türkiye ranks 97th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.